Uterine Sarcoma

Overview

Uterine sarcoma is a rare cancer that develops in the muscle or supporting (connective) tissue of the uterus, rather than in the womb lining where the much more common endometrial cancer arises. Types include leiomyosarcoma (from the muscle wall), endometrial stromal sarcoma, and other less common forms, which behave and are treated differently.

Because uterine sarcomas are uncommon and varied, care is best delivered in a specialist gynaecological cancer centre by a multidisciplinary team. Treatment centres on surgery, sometimes with radiotherapy or chemotherapy depending on the type and stage. Accurate diagnosis is essential to guide the right approach.

This page is an educational overview only and is not medical advice. Diagnosis and treatment must be arranged with a qualified gynaecological oncology team, and no outcome can be guaranteed.

Who May Need This

Assessment may be needed by women with abnormal vaginal bleeding — particularly after the menopause or between periods — a pelvic mass or pressure, pelvic pain, or a uterus or fibroid that appears to be growing quickly. Bleeding after the menopause should always be investigated.

Uterine sarcomas are rare, and most such symptoms are caused by benign conditions such as fibroids. Risk may be slightly higher after previous pelvic radiotherapy or with certain rare inherited conditions. Only a specialist can determine whether symptoms are due to a sarcoma, after examination, imaging and, where possible, biopsy.

When It May Be Recommended

Surgery is generally recommended when imaging suggests a uterine tumour that can be removed and to establish the diagnosis, since sarcomas can be difficult to confirm before surgery. The extent of surgery depends on the suspected or confirmed type and stage and the person's situation.

Radiotherapy or chemotherapy may be recommended after surgery for certain types and stages, or when the cancer cannot be completely removed. When the disease has spread, treatment focuses on control and symptom relief. Because these cancers are rare, decisions are made by a specialist multidisciplinary team.

Diagnosis and Evaluation

Evaluation includes a pelvic examination and imaging, usually ultrasound and MRI, which help assess a uterine mass, and CT or PET to check for spread. A biopsy of the womb lining may be taken, but sarcomas arising in the muscle wall can be hard to sample, so the diagnosis is sometimes confirmed only after surgery.

Blood tests and an assessment of general health complete the work-up. Because uterine sarcomas can resemble benign fibroids, careful specialist assessment is important. All results are reviewed by the multidisciplinary team, and a second opinion at a specialist centre can be valuable.

Treatment Options

The main treatment is surgery, usually a hysterectomy (removal of the uterus), often with the cervix and, in many cases, the ovaries and fallopian tubes, depending on the type, stage and the person's age and situation. Removing lymph nodes or other tissue may be considered in certain cases.

Radiotherapy may be used to reduce the risk of recurrence in the pelvis for some types, and chemotherapy or hormone therapy may be used depending on the sarcoma type and stage, or for advanced disease. The best combination is individualised by the specialist team.

How It Is Performed

Surgery is performed under general anaesthesia. For suspected or confirmed sarcoma, the uterus is generally removed intact to avoid spreading tumour cells; this means certain minimally invasive techniques that fragment tissue (morcellation) are avoided when sarcoma is a possibility. Depending on the plan, surgery is done through an abdominal incision or, in selected cases, minimally invasively with the specimen removed intact.

The removed tissue is examined carefully to confirm the exact type, grade, stage and whether margins are clear, which is crucial for planning any further treatment. Radiotherapy and chemotherapy, when used, are given as planned courses after recovery from surgery.

Preparation

Preparation includes completing imaging and any biopsy, standard pre-operative tests, and a discussion of the effects of surgery, including that removing the uterus ends the ability to carry a pregnancy and that removing the ovaries causes menopause. Your team reviews medicines and gives fasting instructions.

If you are travelling for treatment, bring all imaging and any pathology results. Plan an in-country stay covering surgery and initial recovery, arrange a companion, and organise continuing gynaecological oncology follow-up with your home team before travelling.

Benefits and Expected Goals

The goal of surgery is to remove the cancer completely where possible, confirm the diagnosis and stage, and, with any additional treatment, reduce the risk of recurrence. Removing the tumour can also relieve symptoms such as bleeding, pressure or pain.

Benefits depend heavily on the type, grade, stage and whether the sarcoma can be fully removed, and cannot be guaranteed, as some types are aggressive. Your team can explain realistic goals for your specific situation and the importance of follow-up to detect any recurrence.

Risks and Possible Complications

Surgery and additional treatments carry risks that the team works to minimise.

• Bleeding, infection and blood clots after surgery
• Injury to nearby organs such as the bladder or bowel
• Early menopause if the ovaries are removed, and loss of fertility
• Radiotherapy effects in the pelvis and chemotherapy side effects
• The possibility of recurrence, which is why follow-up is important

Your team will explain the risks specific to your operation and treatment. Report heavy bleeding, severe pain, fever or wound problems promptly after surgery.

Recovery, Follow-up & Aftercare

Recovery from a hysterectomy usually involves a hospital stay of a few days (longer for open surgery) and several weeks to regain full strength, avoiding heavy lifting for a period. If the ovaries are removed, menopausal symptoms may need management. Any radiotherapy or chemotherapy has its own recovery.

Follow-up includes examinations and imaging to detect recurrence early, plus support for menopausal or other effects. Because uterine sarcomas can recur, structured follow-up is important. If you were treated abroad, arrange this ongoing care with your home team and carry your pathology and operation details.

Medical Tourism Planning

Because uterine sarcoma is rare and requires careful surgery, choose a JCI- or ISO-accredited hospital with an experienced gynaecological oncology service, specialist pathology, and access to radiation and medical oncology. Confirm the surgeon's experience with uterine sarcoma and the surgical plan in writing.

Plan an in-country stay covering surgery and initial recovery, request a written treatment plan and cost estimate, and arrange continuing gynaecological oncology follow-up with your home team. Carry your pathology report and consider medical travel insurance.

Estimated Cost Factors

Cost depends on the type and extent of surgery, the surgical approach, the length of hospital stay, and whether radiotherapy, chemotherapy or hormone therapy is needed. Imaging, specialist pathology, and management of any complications also affect the total.

Many destinations offer gynaecological cancer surgery at a fraction of typical US prices, but costs vary widely by case and cannot be judged from online figures. Always request a personalized written quote detailing what is included before deciding.

Choosing a Hospital or Specialist

Look for a hospital with recognised accreditation, an experienced gynaecological oncology team, specialist pathology able to characterise sarcomas, and access to radiation and medical oncology. Confirm the surgeon's experience with uterine sarcoma and that a multidisciplinary team guides decisions.

Ask about international patient services, interpreter support, and how follow-up and any further treatment would be coordinated with your home doctors. Written treatment and cost plans are signs of a quality programme.

Alternatives

Because surgery is central, "alternatives" mainly concern the extent of surgery and which additional treatments — radiotherapy, chemotherapy or hormone therapy — are used, based on the type and stage. For advanced disease, systemic treatment and supportive care are the focus.

Clinical trials may offer newer options, particularly for aggressive or advanced sarcomas. Each approach has different benefits and risks. Discuss all options with your gynaecological oncology team so the plan fits the sarcoma type, stage and your priorities.

Questions to Ask Your Doctor

• What type, grade and stage of uterine sarcoma do I have?
• What surgery do you recommend, and will my ovaries be removed?
• Will I need radiotherapy, chemotherapy or hormone therapy as well?
• How will treatment affect my menopause and fertility?
• What are the specific risks in my case?
• What are the realistic goals of treatment, and what follow-up will I need?
• If I travel, how will follow-up be arranged at home?
• What is included in the written cost estimate?